The guidelines for the diagnosis and treatment of spasticity

Journal of Neurosurgical Sciences

Volumn 50, Issue 4, 2006, Pages 101-105

  Dones, I ^a,b   Nazzi, V ^a   Broggi, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b NONE   (Italy)

Author keywords

Guidelines; Spasticity, diagnosis; Spasticity, therapy

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CLONIDINE; DANTROLENE; DIAZEPAM; TIZANIDINE;

ALERTNESS; ATAXIA; DIAGNOSTIC TEST; DIZZINESS; DROWSINESS; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; FATIGUE; HUMAN; LIVER TOXICITY; MOTOR PERFORMANCE; MUSCLE HYPERTONIA; MUSCLE WEAKNESS; NERVE SURGERY; PALLIATIVE THERAPY; PRACTICE GUIDELINE; RATING SCALE; SHORT SURVEY; SIDE EFFECT; SOMNOLENCE; SPASTICITY; TENOTOMY; URINE RETENTION;

BACLOFEN; BOTULINUM TOXIN TYPE A; GAIT; HUMANS; MUSCLE SPASTICITY; OCCUPATIONAL THERAPY;

EID: 33846445640     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP. Spasticity: disorder of motor control. Chicago: Year Book Medical Publishers; 1980.p.458-53.
2. Sherrington CS. The integrative action of the nervous system. London: Archibald Constable; 1906.
3. Gros C. Spasticity. Clincal classification and surgical treatment. In: Krayenbuhl E, editor. Advances and technical standards in Neurosurgery Wien, New York: Springer; 1979;6.p.55-97.
4. Rawlins PK. Intrathecal baclofen therapy over 10 years. J Neurosci Nurs 2004;36:322-7.
5. Meythaler JM, Clayton W, Davis LK, Guin-Renfroe S, Brunner RC. Orally delivered baclofen to control spastic hypertonia in acquired brain injury. J Head Trauma Rehabil 2004;19:101-8.
6. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS. Long term effect of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psych 2004;75:1553-7.
7. Gekht AB, Burd GS, Selikhova MV, Jaish F, Beliakov W. Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke. Zh Nevrol Psikhiatr 1998;98:22-9.
8. Calabresi PA. Diagnsis and management of multiple sclerosis. Am Fam Physician 2004;70:1935-44.
9. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004;10:589-95.
10. Badhwar A, Jansen A, Andermann F, Pandolfo M, Andermann E. Striking intrafamilial phenotypic variability and spastic paraplegia in the presence f similar homozygous expansions of the FRDA1 gene. Mov Disord 2004;19:1424-31.
11. Tabarki B, Yacoub M, Tilili K, Trabelsi A, Dogui M, Essoussi AS. Familial spastic paraplegia as the presenting manifestation in patients with purine nucleoside phosphorylase deficiency. J Child Neurol 2003;18:140-1.
12. Debantel A, McWilliams S, Auysh D, Echol C, Sambuughin N, Sivakumar K. Novel mutation of the spastin gene in familial spastic paraplegia. Clin Genet 2001;59:364-5.
13. Ashley-Koch A, Bonner ER, Gaskell PC, West SG, Tim R, Wolpert CM et al. Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia. Neurogenetics 2001;3:91-7.
14. Barhoumi C, Amouri R, Ben-Hamida C, Ben-Hamida M, Machghoul S, Gueddiche M et al. Linkage of a new locus for autosomal recessive axonal form f Charcot-Marie Tooth disease to chromosome 8q21.3. Neuromuscul Disord 2001;11:27-34.
15. Milano JB, Neto MC, Hunbevicz SC, Arruda WO, Ramina R, Barros E Jr. Intrathecal baclofen for spasticity in primary lateral sclerosis. J Neurol 2005, Mar 29.
16. Sindou M, Abdennebi B, Boisson D, Eyssette M, Goutelle A. Traitement du pied spastique par la neurotomie sélective du nerf tibial. Neurochirurgie 1985;31:189-97.
17. Mertens P. Les neurotomies périphériques dans le traitement des troubles spastiques des membres. Thèse Médicine n. 471, Lyon, 1987.
18. Sindou M, Mertens P. Selective neurotomy of the tibial nerve for treatment of the spastic foot. Neurosurgery 1988;23:738-44.
19. Brunelli G, Brunelli F. Hyponeurotisation sélective microchirurgicale dans les paralysies spastique. Ann Chir Main 1983;2:277-80.
20. Brunelli G, Brunelli F. Hyponeurotization in spastic palsies (selective partial denervation). In: Textbook of microsurgery. Paris: Masson; 1988.p.861-5.
21. Decq P, Filipetti P, Fevet A, Djindjian M, Saraoui A, Keravel Y. Peripheral selective neurotomy of the brachial plexus collateral branches for the treatment of the spastic shoulder: anatomical study and clinical results on five patients. J Neurosurg 1997;86:648-53.
22. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1:1078.
23. Penn RD, Kroin JS. Continous intrathecal baclofen for severe spasticity. Lancet 1985;2:125-7.
24. Suputtitada A. Local botulinum toxin type A injections in the treatment of spastic toes. Am J Phys Med Rehabil 2002;81:770-5.
25. Muller H, Zierski J, Dralle D. Pharmacokinetics of intrathecal baclofen. In: Muller E, Zierski G, Penn A eds. Local spinal therapy of spasticity. Berlin: Springer Verlag; 1988.p.223-6.
26. Azouvi P, Mane M, Thiebaut JB: Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996;77:35-9.
27. Gianino JM, York MM, Paice JA. Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 1998;30:47-54.
28. Penn RD. Intrathecal baclofen for spasticity of spinal origin:seven years of experience. J Neurosurg 1992;77:236-40.